Major	O
amyloid	B:C0014442
-β-	I:C0014442
degrading	I:C0014442
enzymes	I:C0014442
,	O
endothelin	B:C1567265
-	I:C1567265
converting	I:C1567265
enzyme	I:C1567265
-	I:C1567265
2	I:C1567265
and	O
neprilysin	B:C0025250
,	O
are	O
expressed	B:C1171362
by	O
distinct	O
populations	O
of	O
GABAergic	B:C0815002
interneurons	I:C0815002
in	O
hippocampus	B:C0019564
and	O
neocortex	B:C0175173
.	O

Impaired	O
clearance	O
of	O
amyloid	B:C0078939
-β	I:C0078939
peptide	I:C0078939
(	O
amyloid	B:C0078939
-	I:C0078939
β	I:C0078939
peptide	I:C0078939
)	O
has	O
been	O
postulated	O
to	O
significantly	O
contribute	O
to	O
the	O
amyloid	B:C0002716
accumulation	B:C4055506
typical	O
of	O
Alzheimer	B:C0002395
's	I:C0002395
disease	I:C0002395
.	O

Among	O
the	O
enzymes	B:C0014442
known	O
to	O
degrade	O
amyloid	B:C0078939
-β	I:C0078939
peptide	I:C0078939
in	B:C1515655
vivo	I:C1515655
are	O
endothelin	B:C2745878
-	I:C2745878
converting	I:C2745878
enzyme	I:C2745878
(	B:C0246118
ECE	I:C0246118
)	I:C0246118
-	I:C0246118
1	I:C0246118
,	O
ECE	B:C1567265
-	I:C1567265
2	I:C1567265
,	O
and	O
neprilysin	B:C0025250
(	O
neprilysin	B:C0025250
)	O
,	O
and	O
evidence	O
suggests	O
that	O
they	O
regulate	O
independent	O
pools	O
of	O
amyloid	B:C0078939
-β	I:C0078939
peptide	I:C0078939
that	O
may	O
be	O
functionally	O
significant	O
.	O

To	O
better	O
understand	O
the	O
differential	B:C1327622
regulation	I:C1327622
of	O
amyloid	B:C0078939
-β	I:C0078939
peptide	I:C0078939
concentration	O
by	O
its	O
physiological	B:C0014442
degrading	I:C0014442
enzymes	I:C0014442
,	O
we	O
characterized	O
the	O
cell	B:C0007634
and	O
region	B:C1171362
-	I:C1171362
specific	I:C1171362
expression	I:C1171362
pattern	O
of	O
ECE	B:C0246118
-	I:C0246118
1	I:C0246118
,	O
ECE	B:C1567265
-	I:C1567265
2	I:C1567265
,	O
and	O
neprilysin	B:C0025250
by	O
in	B:C0162788
situ	I:C0162788
hybridization	I:C0162788
and	O
immunohistochemistry	B:C0021044
in	O
brain	B:C0006104
areas	I:C0006104
relevant	O
to	O
Alzheimer	B:C0002395
's	I:C0002395
disease	I:C0002395
.	O

In	O
contrast	O
to	O
the	O
broader	O
distribution	O
of	O
ECE	B:C0246118
-	I:C0246118
1	I:C0246118
,	O
ECE	B:C1567265
-	I:C1567265
2	I:C1567265
and	O
neprilysin	B:C0025250
were	O
found	O
enriched	O
in	O
GABAergic	B:C0815002
neurons	I:C0815002
.	O

ECE	B:C1567265
-	I:C1567265
2	I:C1567265
was	O
majorly	O
expressed	B:C1171362
by	O
somatostatin	B:C0037659
-	O
expressing	B:C1171362
interneurons	B:C0021792
and	O
was	O
active	O
in	O
isolated	O
synaptosomes	B:C0039067
.	O

neprilysin	B:C0025250
messenger	B:C0035696
RNA	I:C0035696
was	O
found	O
mainly	O
in	O
parvalbumin	B:C0030616
-	O
expressing	B:C1171362
interneurons	B:C0021792
,	O
with	O
neprilysin	B:C0025250
protein	B:C0033684
localized	O
to	O
perisomatic	B:C0039062
parvalbuminergic	I:C0039062
synapses	I:C0039062
.	O

The	O
identification	O
of	O
somatostatinergic	B:C0039062
and	O
parvalbuminergic	B:C0039062
synapses	I:C0039062
as	O
hubs	O
for	O
Aβ	B:C0597304
degradation	I:C0597304
is	O
consistent	O
with	O
the	O
possibility	O
that	O
amyloid	B:C0078939
-β	I:C0078939
peptide	I:C0078939
may	O
have	O
a	O
physiological	O
function	O
related	O
to	O
the	O
regulation	B:C2756011
of	O
inhibitory	B:C3537152
signaling	I:C3537152
.	O

